Recruiting
Adenocarcinoma pancreas+1
RecruitingStudy of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection
Registered drugNo placebo
Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection
Registered drugNo placebo
- Disease:Adenocarcinoma pancreasCarbohydrate antigen 19-9
- Substances:Calcium FolinateCapecitabine+5
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Calcium Folinate
- Sponsor:Universitaetsklinikum Ulm AöR
